Navigation Links
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
Date:8/6/2008

MOUNTAIN VIEW, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for the quarter and six month period ended June 30, 2008 and provided an update on the Company's progress with its product development candidates. The net loss for the quarter and six month period ended June 30, 2008, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $14.1 million and $28.7 million, respectively, compared to a net loss of $10.3 million and $21.2 million in the comparable periods in 2007. Alexza had consolidated cash, cash equivalents and marketable securities (including investments held by Symphony Allegro) at June 30, 2008 of $95.3 million.

"Alexza continues to make significant progress with our lead program, AZ-004 (Staccato(R) loxapine), which is being developed for the treatment of acute agitation in schizophrenic or bipolar disorder patients," said Thomas B. King, President and CEO of Alexza. "During the first seven months of 2008, we initiated and completed the dosing of our first AZ-004 Phase 3 clinical trial, and have initiated dosing of our second AZ-004 Phase 3 clinical trial. In addition, we had clinical readouts from clinical trials with AZ-104, AZ-007 and AZ-002. We are also scaling up our manufacturing, quality systems, regulatory affairs and commercial operations as we prepare for the future commercialization of AZ-004."

Financial Results - Periods Ended June 30, 2008 and 2007

GAAP operating expenses were $20.5 million and $39.7 million in the quarter and six month period ended June 30, 2008, compared to $14.2 million and $28.0 million for the comparable periods in 2007. The increases resulted primaril
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... to announce the chairman of the Summit Mr. Phani ... He will be joined by the expert speaker faculty including ... this May 11 – 12, at The Hotel Kabuki in ... agenda is available for download on the event website, which ...
(Date:5/5/2015)... May 5, 2015  Accuray Incorporated (Nasdaq: ARAY ... the Bank of America Merrill Lynch 2015 Healthcare Conference ... May 12, 2015 at 2:20pm PT.   ... on the Investor Relations page of the Company,s website ... presentation will begin approximately one hour after the conclusion ...
(Date:5/5/2015)... -- Image Stream Medical, a leader in OR video collaboration ... the largest group purchasing organizations, serving four out of ... the three-year agreement, Image Stream,s portfolio of EasySuite™ OR ... to MedAssets members beginning on July 1, 2015. ... Eddie Mitchell said, "We ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Image Stream Medical Announces Agreement with MedAssets 2
... Sosei Group Corporation,("Sosei"; TSE Mothers Index: 4565), ... Japanese Phase III clinical trial for the,emergency contraceptive ... rights to the product in Japan from HRA ... evaluate the safety and prevented,pregnancy rate of SOH-075 ...
... Americans, WASHINGTON, July 9 In a congressional,hearing ... the,safety and importance of the research programs operated by ... absolute commitment to its patients,while expressing regret that even ... "VA has an outstanding research program, and has been ...
Cached Medicine Technology:Sosei Announces Completion of Phase III Trial for NorLevo(R) 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3
(Date:5/5/2015)... In the upbeat Moms Helping Moms video, ... to support each other. Parenting is a tough job, ... it so much easier. Mothers talk about how relating ... alone and help them realize there’s no perfect parent; everyone ... are clearly dear friends share that it's just that, the ...
(Date:5/5/2015)... 2015 Major League Ultimate (MLU) was ... that ultimate Frisbee™ is home to many amazing athletes, ... engages the world. Nike Ultimate Camps’ goal of spreading ... for young athletes to learn about the sport and ... perfect fit. , The Nike Ultimate Camp in Philadelphia ...
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... Igantia , an emerging biotechnology and ... initiative to examine key biological milestones during a woman’s ... Scientists at Igantia believe that better understanding of the ... her menstrual cycle to her transition into menopause, they ... extend the lifespan. , By recently announcing the ...
(Date:5/5/2015)... 05, 2015 HealthSlide, Inc ... interoperability solutions for hospitals nationwide, has announced the ... Hospital CIOs and CTOs can access the calculator ... shows both initial and ongoing savings of switching ... “Our nation’s hospitals pay an average of $300,000 ...
Breaking Medicine News(10 mins):Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:HealthSlide Launches ROI Cost Calculator 2
... to the active ingredient in marijuana but produced naturally ... may offer a novel target for treating Parkinson's disease. ... in the latest issue of the journal Nature, show ... used in the brain to transmit signals - form ...
... the February issue of Current Directions in Psychological Science ... pass on his genes during post-copulation as well, a ... Todd Shackelford and Aaron Getz at Florida Atlantic University ... competing for fertilizations." ,For a monogamous ...
... of Health of Jamaica has confirmed 280 cases of malaria ... 2006 and 3 February 2007. Of these reported cases, 264 ... in St Thomas and 1 in Clarendon. There have been ... of Health is receiving technical cooperation from the WHO Regional ...
... Todaro was talking to researchers at the Fred Hutchinson Cancer Research ... growth by slowing the rate at which tumor cells divide. ... reaction in reverse and get cells to grow faster? ... up with techniques for increasing crop yields with canola, corn and ...
... and thought to hold great promise at overcoming the ... useful for helping women with the condition achieve pregnancy ... clomiphene, report researchers in an NIH research network. ... yet to compare the two drugs in helping women ...
... link between zinc supplementation and reduced atherosclerosis in rabbit ... to their hypothesis that the effect may be due ... ,Researchers from the National University of Singapore reported ... year that supplementation of a high cholesterol diet with ...
Cached Medicine News:Health News:Natural Brain Substance Linked to Parkinson's Symptoms 2Health News:Males Adapt To Battle With Competing Sperm 2Health News:Cancer Research May Help Biofuels 2Health News:Standard Therapy More Effective in Common Fertility Disorder 2Health News:Standard Therapy More Effective in Common Fertility Disorder 3Health News:More Support for Zinc-antiatherogenic Link 2Health News:More Support for Zinc-antiatherogenic Link 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: